PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Iveric Bio Reports the US FDA Acceptance of NDA and Granted Priority Review of Avacincaptad Pegol for Geographic Atrophy

Iveric Bio Reports the US FDA Acceptance of NDA and Granted Priority Review of Avacincaptad Pegol for Geographic Atrophy

February 17, 2023

PharmaShots Weekly Snapshots (February 13 - 17, 2023)

PharmaShots Weekly Snapshots (February 13 - 17, 2023)

February 17, 2023

ALX Oncology Reports the First Patient Dosing of Evorpacept in the P-I Study (ASPEN-07) for the Treatment of Urothelial Cancer

ALX Oncology Reports the First Patient Dosing of Evorpacept in the P-I Study (ASPEN-07) for the Treatment of Urothelial Cancer

February 17, 2023

Fresenius Kabi Launches Stimufend (biosimilar, pegfilgrastim) for Febrile Neutropenia in the US

Fresenius Kabi Launches Stimufend (biosimilar, pegfilgrastim) for Febrile Neutropenia in the US

February 17, 2023

Applied Therapeutics Reports P-III trial (INSPIRE) Results of AT-007 for Sorbitol Dehydrogenase Deficiency

Applied Therapeutics Reports P-III trial (INSPIRE) Results of AT-007 for Sorbitol Dehydrogenase Deficiency

February 17, 2023

Pfizer Reports P-III Trial Results of Zavegepant for the Acute Treatment of Migraine in Adults

Pfizer Reports P-III Trial Results of Zavegepant for the Acute Treatment of Migraine in Adults

February 17, 2023

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us